Xiaopan Yao PhD

Assistant Professor of Medicine (Medical Oncology)

Departments & Organizations

Cancer Center, Yale

Yale Center for Analytical Sciences (YCAS)

Medical Oncology


Research Interests

Design and analysis for phase I-III clinical trials in oncology


Education

  • Ph.D., Pennsylvania State University, 2007
  • M.S., Pennsylvania State University, 2007

Selected Publications

  • H. F. Fernandez, Z. Sun, X. Yao, M. R. Litzow, S. M. Luger, E. M. Paietta, J. Racevskis, G. W. Dewald, R. P. Ketterling, J. M. Bennett, J. M. Rowe, H. M. Lazarus, M. S. Tallman. Anthracycline dose intensification in acute myeloid leukemia. New England Journal of Medicine 2009; 361:1249–1259.
  • R. A. Mesa, X. Yao, L. D. Cripe, C. Y. Li, A. Tefferi, M. S. Tallman. Combination lenalidomide and prednisone for primary and post polycythemia vera/essential thrombocythemia myelofibrosis (MF): An Eastern Cooperative Oncology Group (ECOG) Phase II Trial. Blood; 2010 Jul 22.
  • P. Van Vlierberghe, T. Palomero, H. Khiabanian, J. Van der Meulen, M. Castillo, N. Van Roy, B. De Moerloose, J. Philippé, S. González-García, M. L. Toribio, T. Taghon, L. Zuurbier, B. Cauwelier, C. J. Harrison, C. Schwab, M. Pisecker, S. Strehl, A. W. Langerak, J. Gecz, E. Sonneveld, R. Pieters, E. Paietta, J. M. Rowe, P. H. Wiernik, Y. Benoit, J. Soulier, B. Poppe, X. Yao, C. Cordon-Cardo, J. Meijerink, R. Rabadan, F. Speleman, A. Ferrando. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nature Genetics 2010; 42: 338–342.

collapsible-single-column-one-thumbnailphotobooksupi=13692723/WCF/News.svc/

Latest News

3

Edit Profile